Stephen Mackinnon

发表

Final results of UK multi-centre, phase II study of Campath-1h dose de-escalation prior to non-myeloablative hla-identical sibling stem cell transplantation

Guillermo Orti, Ks Peggs, Matthew Collin, 2010 .

Tumor-activated human NK cells - Potential for "off-the-shelf" immunotherapy

Stephen Mackinnon, Mark W. Lowdell, Robert H. Anderson, 2007 .

Older age is not a barrier to successful allogeneic BMT.

Pd Kottaridis, Stephen Mackinnon, B Miller, 1999 .

Imatinib mesylate--the new gold standard for treatment of chronic myeloid leukemia.

Stephen Mackinnon, S. Mackinnon, K. Peggs, 2003, The New England journal of medicine.